Case: A 16-month-old, previously healthy girl presented with fever for 2 days. Other symptoms included rhinorrhea, cough, decreased activity, and oral ulcerations associated with decreased oral intake. The child had no vomiting, diarrhea, rashes, head trauma or other injuries. There were no sick contacts. The child's father denied home medications and ingestions. Immunizations were up to date and included her fi rst infl uenza vaccine.
In triage the child had a temperature of 39.8°C, pulse of 164 beats per minute, respiratory rate of 20 breaths per minute, and oxygen saturation of 98%. She appeared tired and irritable but was consolable. She was given ibuprofen (10 mg/kg/dose). As the child was placed in the examination room, she became unresponsive with rightward eye deviation, drooling, and symmetric tonic-clonic seizure activity. The seizure continued for >10 minutes despite rectal diazepam (0.1 mg/kg/dose) and concluded after intravenous midazolam (0.1 mg/kg/dose). She was also given acetaminophen (15 mg/kg/dose per rectum). A 20-minute postictal period was followed by a second 10-minute seizure, which required intravenous (IV) midazolam (0.1mg/kg/dose) and a load of IV fosphenytoin (20 mg/kg/dose).
Question: What are current recommendations for the evaluation and management of a child with a complex febrile seizure (CFS)?
Discussion: Recent guidelines on management of simple febrile seizures (SFS) offer support for clinicians caring for children with this condition. 1 However, similar consensus and guidance is harder to fi nd for management of CFS in pediatrics. Febrile seizures affect 2% to 5% of children, usually aged between 6 months and 5 years. 2 From 25% to 30% of febrile seizures are classifi ed as CFS, 2,3 defi ned as a those seizures associated with fever and with any of the following characteristics: duration >15 minutes, recurrence within 24 hours, focality, and/or associated neurologic abnormalities. 4 A meta-analysis by Offringa et al 5 showed that the following criteria increase the risk of a CFS: age <12 months, history of unprovoked seizures in fi rst-degree relatives, and a focal initial febrile seizure. Additionally, the risk of a future unprovoked seizure after a simple febrile seizure is 2.5%; only slightly higher than the 1.4% risk of unprovoked seizures in the general population of 2-to 25-year-olds. In contrast, the risk of future unprovoked seizures in a patient with a CFS is higher: 6% to 8% with 1 feature of CFS, 17% to 20% with 2 features (eg, prolonged and focal), and 49% with 3 features. 6 In 2008, an American Academy of Pediatrics practice guideline advised against the use of intermittent or continuous anticonvulsant medication for children with SFS. 7 In additional recommendations from 2011, the Academy further suggested that, in general, an SFS does not require diagnostic evaluation for other than the source of the fever. 1 A lumbar puncture is an option in children with SFS who are between the ages of 6 and 12 months and for those who are underimmunized or on antimicrobial therapy at the time of presentation.
1 Further evaluation, specifi cally electroencephalography (EEG); blood studies such as serum electrolytes, calcium, phosphorus, magne sium, blood glucose, or a complete blood cell count; or neuroimaging, is not recommended. 1 Because CFSs are more likely to recur and particularly because they are more likely than SFS to have a harmful etiology, potentially requiring immediate treatment, physicians treating a child with a CFS are more likely to pursue a thorough diagnostic evaluation. Although guidelines for management of SFS are available, similar guidelines for CFS are more diffi cult to fi nd. This has resulted in wide variability in care of children with this condition. In a recent survey of 353 emergency physicians in 10 U.S. hospitals asked about management of patients with CFS, 54% indicated that they would obtain blood tests, 62% indicated they would obtain urine, 34% indicated that they would perform a lumber puncture, and 36% would perform neuroimaging. Case continuation: Following treatment with anticonvulsants for persistent seizures, the patient's neurologic status failed to improve to baseline. The child was intubated for a Glasgow Coma Scale score of 7 and was transferred to a PICU. Discussion: Despite the fact that 36% of physicians in the emergency medicine survey obtained neuroimaging in patients with CFS, earlier studies have shown that, in the absence of a history of trauma or signs and symptoms of increased intracranial pressure, routine neuroimaging in children with CFS is of low yield. [9] [10] [11] [12] [13] These fi ndings were confi rmed in a more recent study from Children's Hospital of Boston in which the authors sought to assess the risk of intracranial pathology requiring immediate intervention among children presenting with their fi rst CFS.
14 In a 7-year retrospective cohort study, medical records of 526 patients, aged 6 to 60 months, who were otherwise healthy but presenting with CFS to this urban tertiary care pediatric emergency department were reviewed. Patients were excluded from evaluation if their seizures concluded within 15 minutes with IV or rectal benzodiazepine administration. Of the 526 patients reviewed, 268 underwent computed tomography (CT), 6 underwent magnetic resonance imaging (MRI), and 8 patients had both. Four of 268 patients had signifi cant fi ndings (2 intracranial bleeds, 1 acute disseminated encephalomyelitis, and 1 with cerebellar abnormalities). In a 6-month follow-up, none of those patients who avoided neuroimaging returned with later central nervous system (CNS) fi ndings. 14 In this and other studies, the largest percentage of CFS patients was the group of children who experienced 2 seizures in 24 hours. 4, 14 None of the 4 children with CNS abnormalities in this study had a CFS based on recurrence of seizures within 24 hours.
14 In a separate retrospective chart review of 45 patients who had neuroimaging after a fi rst CFS, 7 (16%) had abnormal fi ndings, but none required emergent intervention. 15 Based on these studies, emergent neuroimaging for well-appearing patients with a normal neurologic examination after a CFS is not recommended, especially in those children meeting criteria solely by having a second seizure within 24 hours.
There is also lack of consensus on the necessity of laboratory testing in children with CFS. 9 The reason for the lack of consensus may be based on the wide variability in the patients with CFS. A child with a CFS who is well appearing and has had 2 brief seizures in 24 hours may have a similar prognosis as a child with SFS, whereas a child who fails to return to his or her neurologic baseline after a CFS may warrant a different evaluation. There is compelling evidence that routine measurement of electrolytes or glucose is not required in SFS. 16 However, in a child with febrile status epilepticus (FSE), defi ned as seizures or series of seizures that last ≥30 minutes without recovery of normal mental status, evaluation for hypoglycemia, and other electrolyte abnormalities is indicated. Similarly, a child with FSE or one who is obtunded after a self-limited seizure may be at risk for toxic ingestion. Therefore, in the case of CFS, clinical judgment based on variable presentations must direct the laboratory testing. Testing may include a complete blood count, blood culture, electrolytes, glucose, and a toxicology screen.
Concern for bacterial meningitis as a cause for CFS has long precipitated lumbar puncture as part of this ® AN OFFICIAL JOURNAL OF THE AMERICAN ACADEMY OF PEDIATRICS evaluation. 17 Decreasing prevalence of bacterial meningitis and more recent evidence that CFS alone is a rare presentation for bacterial meningitis have now brought this practice into question. In a study by Green et al of 111 children with bacterial meningitis who presented with seizures, 103 were classifi ed as obtunded or comatose at presentation. The remaining 8 children all had some other clinical fi nding, including an abnormal neurologic examination or nuchal rigidity, to indicate meningitis. 18 Other researchers have reached similar conclusions. Kimia et al reported that of 337 children who underwent lumbar puncture after CFS, 3 had bacterial meningitis. 19 Two with Streptococcus pneumoniae meningitis had signifi cant changes in mental status in addition to CFS. A third child had a positive blood culture but was well appearing and had no growth on a culture of bloody cerebral spinal fl uid (CSF). Teach and Geil reported that of the 243 children with febrile seizures (89% simple and 11% complex), none had acute bacterial meningitis. 20 Also, Seltz et al, in a retrospective chart review of 390 patients with CFS, found 6 cases of meningitis and 1 case of herpes simplex virus (HSV) encephalitis (HSE). All of these patients had altered mental status on presentation. 21 Patients with FSE may present an exception. 22 Chin et al in a prospective populationbased study, reported that as many as 17% of children with FSE were found to have acute bacterial meningitis. 22 Therefore, a lumbar puncture should be reserved for children aged <12 months, febrile status epilepticus, prolonged change in mental status, nuchal rigidity, or focal neurologic signs and symptoms.
Several studies have called into question the utility of an EEG in children with CFS. 23, 24 However, EEG may be used as a means of establishing prognosis for development of epilepsy. The National 4 Additionally, children with CFS alone have a fi vefold increase risk of developing epilepsy compared with the general population. 25 That risk is increased incrementally in children with >1 of the defi ning characteristics of CFS (duration, focality, recurrence, lasting change in neurologic status). 6 Delaying the EEG until ≥7 days after the seizure activity will decrease false-positive results due to generalized slowing caused by the seizures. 26 Therefore, an outpatient EEG is indicated in patients with abnormal neurodevelopment, family history of epilepsy, or >1 feature of CFS. This conclusion was also supported by a recent review by Patel et al.
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Case continuation: A head CT was positive for areas of hyperattenuation, likely representing blood but nonspecifi c; therefore, additional studies, including an MRI and a lumbar puncture, were obtained. The MRI (Fig 1) showed restricted diffusivity within the bilateral posterior frontal and anterior parietal lobes, consistent with viral encephalitides with tropism for these regions of the brain. Sparing of the basal ganglia decreased the likelihood of a toxic/metabolic insult. Additionally, a vascular etiology was less likely due to the symmetry and normal appearance of the vessels in the magnetic resonance angiography/venography. The lumbar puncture showed 25 white blood cells and 32 700 red blood cells (RBCs) per high-powered fi eld. CSF was subsequently positive for HSV polymerase chain reaction (PCR), with later serologic confi rmation for HSV-1. MRI fi ndings, along with the positive HSV PCR, were consistent with the diagnosis of HSE. The patient was initially treated with IV ceftriaxone (100 mg/kg/dose), vancomycin (15 mg/kg/dose), and acyclovir (20 mg/kg/dose), but later the antibiotics were discontinued, and the patient completed a 21-day course of intravenous acyclovir (20 mg/kg/ dose, 3 times a day). The child's seizures recurred and proved diffi cult to treat. She was discharged to a chronic care facility after a 9-day hospital stay. At the time of discharge, she had signifi cant neurologic impairment but was continuing to make slow progress in physical and occupational therapy.
Question: Which patients with CFS should be worked up for the possibility of HSE?
Discussion: HSE is a rare cause of CFS in children. In an investigation of 390 children with CFS, Seltz et al found that 0.3% had HSE. 21 Both HSV-1 and HSV-2 infections have been implicated with CNS disease. However, HSE is caused by HSV-1 infections in 93% to 96% of cases. 28 There may be a difference in neurologic manifestations and pathways of transmission to the CNS for these 2 types of HSV infections. The majority of patients with CNS disease with HSV-2 develop meningitis, with newborns and adults comprising the typical patient population. In contrast, patients with HSV-1 CNS infection are primarily children and develop HSE rather than meningitis. 29 Spread www.hospitalpediatrics.org of HSV-1 to the CNS proceeds by 3 possible pathways; neurogenic, hematogenous dissemination, or spread through the nasopharyngeal mucosa into the cribriform plate. In patients with HSV-2 meningitis, there usually is no involvement of the brain itself, and it is possible that the infection is spread either through neuronal pathways or hematogenous spread. 30 Of all patients with childhood encephalitis, 2% to 5% have historically been associated with HSV. 31 The incidence of childhood encephalitis has been reported as 30 per 100 000 (study between 1950 and 1981). 32 However, a study by Koskiniemi et al showed an overall incidence of childhood encephalitis of 10.5 per 100 000 childyears during a 2-year surveillance period (1993) (1994) , of which ~5% was attributed to HSE. 33 In a more recent 12-year prospective study, Elbers et al also found that HSV accounted for 5% of all cases of acute childhood encephalitis. 34 Therefore, the relative incidence of HSE may have increased compared with the total incidence of the childhood encephalitis. This is most likely due to widespread vaccination for other viruses such as mumps, measles, and rubella, all of which historically contributed to the incidence of childhood encephalitis.
Diagnosis of HSE cannot be made through clinical fi ndings because they are nonspecifi c. Children can present with fever, malaise, fussiness, decrease oral intake, and eventually irritability, lethargy, or other neurologic abnormalities. The most common fi ndings in patients with HSE are altered mental status, fever, and seizures. 31 Laboratory diagnosis is also not based on a single test. CSF fi ndings include pleocytosis with a predominance of lymphocytes, which will be present in most of the cases. Currently, the most accurate test is an HSV PCR of the CSF, which is 98% sensitive and 94% specifi c. 35 These fi gures were obtained from several National Institute of Allergy and Infectious Disease Collaborative Antiviral Study Group therapeutic studies of HSE in both adult and pediatric patients. 35 These test characteristics may vary in populations of children alone. In a 12-year prospective study of childhood HSE, Elbers et al reported that in a population of 322 children with encephalitis, 16 children had serologically confi rmed HSV disease, of whom only 12 (75%) had positive CSF HSV PCRs. 34 Additionally, 17% (n = 2), of the patients with positive PCRs had negative PCRs on day 1 and subsequently positive results on days 3 and 7. De Tiege et al reviewed 38 cases of children with HSE and found that eight of 33 had initial negative CSF HSV PCR results. 36 False-negative HSV PCRs most often occur early in the course of the infection. 34, 37 Researchers hypothesize that early in the course of HSE, the virus may be present in brain tissue before spreading to the CSF and meninges. This hypothesis is supported by lack of CSF pleocytosis in some children with HSE as well as negative early CSF HSV PCR. 37 Additionally, there may be a correlation between the location of brain involvement and CSF HSV PCR false negatives in children. De Tiege et al reported a case of a child with PCR-negative HSE involving the left parietal lobe and left thalamus rather than the typical temporal lobe location. 38 In the study of 38 children with HSE mentioned earlier, 40% had frontal, parietal, or occipital lesions. This group had a disproportionately high rate of negative-HSV PCR at diagnosis. This may suggest a different path of HSV access to the CNS in younger patients. 38 The fi nding of CSF RBCs is also inconsistent in children with HSE. In more than half of cases, there are RBCs in the CSF, which is consistent with intracranial hemorrhage. 39 Patients with CSF RBCs may have a worse prognosis. 40 HSV viral cultures are often negative from the CSF. Surface cultures are also of mixed utility because they are not sensitive, and results take up to 5 to 7 days.
In suspected HSV as a cause for CFS, neuroimaging may be useful. In the acute setting, when MRI is not available, a CT scan may show hemorrhagic brain necrosis, appearing as low-density lesions and causing localized mass effect. 41 However, especially early in the course of disease and in the absence of hemorrhagic necrosis, a negative CT scan has poor negative predictive value. 42 Elbers et al reported that in patients with HSE who had normal CT studies followed by MRI, 67% of MRI studies showed signifi cant abnormalities. 34 Additionally, Greenberg et al showed that 5 patients with brain biopsyproven HSE had normal CT scans 1 to 7 days after the onset of illness. 43 MRI is more sensitive in detecting brain lesions and should be used if it is available as the fi rst diagnostic step after clinical assessment. 42, 44 However, even a negative MRI should not stop the clinician from performing further workup of a patient in whom HSE is suspected because associated morbidity and mortality are signifi cant, and as many as 12% of patients with confi rmed HSE have normal MRI neuroimaging. 34, 45 Figure 1 is the T2 fl uid-attenuated inversion recovery (FLAIR) axial image of this patient's brain MRI. The hyperintense signal changes and diffusion limitation especially observed in T2-FLAIR sequences are typical for changes seen in the brain of patients with HSE. 46 In any patient in whom there is strong clinical suspicion of HSE, it is critical to ensure early treatment with acyclovir even in a setting of a normal CSF cell count, negative HSV PCR, negative or pending herpes cultures, and negative imaging studies. The recommended dose of acyclovir for children aged 3 months to 12 years is 20 mg/kg/dose administered IV every 8 hours. The dose is adjusted to 10 mg/kg/dose for children >12 years of age. 47 The recommended duration of therapy is 21 days, a duration that has been shown to be associated with a decrease in adverse neurologic outcomes and decreased relapse of symptoms compared with a 14-day course. 34 Without therapy HSE has a 70% mortality rate. 48 Even with acyclovir therapy, the mortality rate at 6 months is 19%. 49 Prompt treatment and longer course therapy have been associated with better long-term neurologic function. 34, 48 Conclusions: CFS comprises a heterogeneous group of processes, and 1 set of guidelines may not be applicable to all patients. For patients with 2 selflimited febrile seizures in 24 hours but a return to normal neurologic status, it may be appropriate to avoid any additional workup, treating these children similarly to those with SFS. A more aggressive approach is warranted for children with other forms of CFS, including those with status epilepticus, altered mental status, focal seizures, or focal neurologic symptoms. Additionally, abnormal physical examination fi ndings including nuchal rigidity and a bulging fontanel, increase the risk of a more serious condition. For these children, a lumbar puncture, other laboratory tests, and imaging may be necessary in the acute visit. EEG is not usually recommended in the acute setting because there may be false positives. Children with >1 feature of CFS (eg, prolonged and focal), abnormal neurodevelopment, and a family history of epilepsy are indicated for follow-up with a neurologist and an outpatient EEG because there is a fi vefold increase in subsequent unprovoked seizures in these children.
In the patient described here, a workup including lumbar puncture and imaging was necessary because she had many worrisome features, including status epilepticus, focal seizures, a change in mental status, and an abnormal neurologic examination. A high index of suspicion for HSE should be maintained in patients with CFS and altered mental status or abnormal imaging consistent with hemorrhagic www.hospitalpediatrics.org necrosis to ensure quick initiation of adequate and appropriate treatment.
